These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 24621885)

  • 1. MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET.
    Zhang Y; Schiff D; Park D; Abounader R
    PLoS One; 2014; 9(3):e91546. PubMed ID: 24621885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-34A inhibits the growth, invasion and metastasis of gastric cancer by targeting PDGFR and MET expression.
    Peng Y; Guo JJ; Liu YM; Wu XL
    Biosci Rep; 2014 Jun; 34(3):. PubMed ID: 24837198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas.
    Bayrak OF; Gulluoglu S; Aydemir E; Ture U; Acar H; Atalay B; Demir Z; Sevli S; Creighton CJ; Ittmann M; Sahin F; Ozen M
    J Neurooncol; 2013 Nov; 115(2):143-51. PubMed ID: 23912551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.
    Li Y; Guessous F; Zhang Y; Dipierro C; Kefas B; Johnson E; Marcinkiewicz L; Jiang J; Yang Y; Schmittgen TD; Lopes B; Schiff D; Purow B; Abounader R
    Cancer Res; 2009 Oct; 69(19):7569-76. PubMed ID: 19773441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-152 inhibits the proliferation and invasion of chordoma cells by targeting
    Fang X; Yan R
    J Int Med Res; 2019 Oct; 47(10):5185-5193. PubMed ID: 31638463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.
    Dai C; Xie Y; Zhuang X; Yuan Z
    Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer.
    Chiyomaru T; Seki N; Inoguchi S; Ishihara T; Mataki H; Matsushita R; Goto Y; Nishikawa R; Tatarano S; Itesako T; Nakagawa M; Enokida H
    Int J Oncol; 2015 Feb; 46(2):487-96. PubMed ID: 25405368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive role of dysregulated miRNAs in chordoma cancer stem-like cell maintenance.
    Tuysuz EC; Gulluoglu S; Yaltirik CK; Ozbey U; Kuskucu A; Çoban EA; Sahin F; Türe U; Bayrak OF
    Exp Cell Res; 2019 Jul; 380(1):9-19. PubMed ID: 30951707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
    Koshizuka K; Hanazawa T; Fukumoto I; Kikkawa N; Matsushita R; Mataki H; Mizuno K; Okamoto Y; Seki N
    J Hum Genet; 2017 Jan; 62(1):113-121. PubMed ID: 27169691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
    Ma Y; Qin H; Cui Y
    Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1.
    Li L; Yuan L; Luo J; Gao J; Guo J; Xie X
    Clin Exp Med; 2013 May; 13(2):109-17. PubMed ID: 22623155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET.
    Zhang Z; Kong Y; Yang W; Ma F; Zhang Y; Ji S; Ma EM; Liu H; Chen Y; Hua Y
    Oncol Rep; 2016 Oct; 36(4):2391-7. PubMed ID: 27513895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
    Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential function of microRNA in chordomas.
    Gulluoglu S; Tuysuz EC; Kuskucu A; Ture U; Atalay B; Sahin F; Bayrak OF
    Gene; 2016 Jul; 585(1):76-83. PubMed ID: 27016303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion.
    Wu X; Cheng YL; Matthen M; Yoon A; Schwartz GK; Bala S; Taylor AM; Momen-Heravi F
    J Exp Clin Cancer Res; 2021 Feb; 40(1):70. PubMed ID: 33596979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells.
    Yamamura S; Saini S; Majid S; Hirata H; Ueno K; Deng G; Dahiya R
    PLoS One; 2012; 7(1):e29722. PubMed ID: 22235332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA.
    Mackiewicz M; Huppi K; Pitt JJ; Dorsey TH; Ambs S; Caplen NJ
    Breast Cancer Res Treat; 2011 Nov; 130(2):663-79. PubMed ID: 21814748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In bone metastasis miR-34a-5p absence inversely correlates with Met expression, while Met oncogene is unaffected by miR-34a-5p in non-metastatic and metastatic breast carcinomas.
    Maroni P; Puglisi R; Mattia G; Carè A; Matteucci E; Bendinelli P; Desiderio MA
    Carcinogenesis; 2017 May; 38(5):492-503. PubMed ID: 28334277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-34a inhibits tumor invasion and metastasis in osteosarcoma partly by effecting C-IAP2 and Bcl-2.
    Wen J; Zhao YK; Liu Y; Zhao JF
    Tumour Biol; 2017 Jun; 39(6):1010428317705761. PubMed ID: 28635396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1.
    Ji F; Zhang H; Wang Y; Li M; Xu W; Kang Y; Wang Z; Wang Z; Cheng P; Tong D; Li C; Tang H
    Bone; 2013 Sep; 56(1):220-6. PubMed ID: 23756231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.